The Strategy Exited Ionis Pharmaceuticals (IONS) Following Sequential Phase 3 Clinical Setbacks
Artisan Partners, an investment management company, released its third-quarter 2026 investor letter for the “Artisan U.S. Small-Cap Growth Strategy”. The letter can be downloaded here.









